Genital Laser & Radiofrequency: Rejuvenation & Tightening

Biophysical Mechanisms

• Laser–tissue interaction: photothermal and photomechanical effects
• Selective photothermolysis: chromophore targets and wavelength selection
• Radiofrequency: resistive heating, collagen denaturation and neocollagenesis
• Fractionated vs non-fractionated delivery: mechanisms and clinical trade-offs

Laser Systems — CO₂, Er:YAG & Diode

• CO₂ fractional (10,600 nm): ablation depth and mucosal remodelling
• Er:YAG (2,940 nm): precise ablation and reduced thermal damage
• Diode laser: LLLT and non-ablative vulvovaginal applications

Radiofrequency — Monopolar, Bipolar & Fractional RF

• Monopolar RF: volumetric heating and collagen tightening
• Bipolar RF: superficial remodelling and laser combination protocols
• Fractional RF: coagulation zone design and vulvovaginal applications
• Parameter optimisation: power, frequency and applicator technique

• Pathophysiology of vaginal laxity: connective tissue changes and clinical assessment
• CO₂ fractional and Er:YAG intravaginal protocols: parameter setting and treatment depth
• Radiofrequency vaginal tightening: monopolar and fractional RF protocol design
• Session frequency, maintenance intervals and evidence-based outcome measurement
• Patient selection, pre-treatment assessment and realistic outcome communication

• GSM pathophysiology: oestrogen deficiency, mucosal atrophy and functional impact
• Evidence base: RCT outcomes and clinical guidelines for laser and RF
• CO₂ fractional laser protocols for atrophic vaginitis: parameter optimisation and monitoring
• RF as adjunct to local hormone therapy: combination treatment algorithm
• Patient-reported outcomes: DIVA index, VAS scales and quality-of-life measurement

• Pathophysiology of SUI: urethral support deficiency and pelvic floor biomechanics
• Evidence for laser and RF in non-surgical SUI: patient selection criteria
• Periurethral laser protocol: applicator placement, depth and parameter optimisation
• Monopolar RF periurethral tightening: protocol design and clinical outcome data
• Combination approach: energy-based SUI with PRP and pelvic floor physiotherapy

Intimate Skin Lightening & Hyperpigmentation

• Pathophysiology: post-inflammatory, hormonal and friction-induced hyperpigmentation
• Laser lightening protocols: Q-switched Nd:YAG, fractional CO₂ and Er:YAG
• Combination RF + mesotherapy depigmentation agents for sustained results
• Fitzpatrick I–VI phototype assessment: device and parameter adaptation by skin type

Lichen Sclerosus — Laser & RF as Non-Surgical Adjuncts

• LS pathophysiology, classification and evidence-based management framework
• CO₂ fractional laser in LS: mechanism, clinical evidence and patient selection
• RF collagen remodelling: symptom reduction and quality-of-life outcomes
• Multimodal protocol: laser/RF with topical corticosteroids and PRP
• Monitoring, treatment response and long-term maintenance strategies

Safety Protocols & Complication Prevention

• Thermal damage control, cooling systems and clinical endpoint recognition
• Contraindications: absolute and relative for laser and RF in the genital region
• Immediate adverse events: burns, pigmentation changes, mucosal injury — recognition and management
• Delayed complications: scarring, textural changes, infection — prevention and treatment

Patient Selection, Consent & Outcome Optimisation

• Evidence-based selection criteria for each laser and RF indication
• Pre-treatment photography, documentation and baseline outcome benchmarking
• Informed consent frameworks specific to energy-based genital procedures
• Post-treatment care, recovery optimisation and follow-up algorithms

• Real patient cases: before-and-after analysis with faculty commentary
• Device troubleshooting: sub-optimal outcomes, adverse events and corrective protocols
• Combination strategy: laser + RF + injectables for synergistic outcomes
• Open Q&A: direct access to faculty for clinical and device-specific questions